anonymous
Guest
anonymous
Guest
You better hope the NBU reps don't leave... who do you think pays your salary? This 10 year old, $2 billion and growing medication. We don't mix well with other divisions? We built this company, so you're welcome for your job. You clearly know nothing. We do have new meds to sell. We have year after year after year. The patent life was ridiculously long with Vyvanse and it's amazing so that's why it's still relevant. Try doing a little research before you post such an asinine comment.
There is a warehouse in Dublin filled with monkeys being trained to be NBU reps. Should take a few weeks to get them ready.